• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与慢性阻塞性肺疾病患者暴露于环境超细颗粒相关的促血栓形成变化:脂质过氧化和全身炎症的作用。

Pro-thrombotic changes associated with exposure to ambient ultrafine particles in patients with chronic obstructive pulmonary disease: roles of lipid peroxidation and systemic inflammation.

机构信息

BIC-ESAT and SKL-ESPC, College of Environmental Sciences and Engineering, Peking University, Beijing, China.

Hebei Technology Innovation Center of Human Settlement in Green Building (TCHS), Shenzhen Institute of Building Research Co., Ltd., Xiongan, China.

出版信息

Part Fibre Toxicol. 2022 Oct 24;19(1):65. doi: 10.1186/s12989-022-00503-9.

DOI:10.1186/s12989-022-00503-9
PMID:36280873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9590143/
Abstract

BACKGROUND

Exposure to particulate matter air pollution is associated with an increased risk of cardiovascular mortality in patients with chronic obstructive pulmonary disease (COPD), but the underlying mechanisms are not yet understood. Enhanced platelet and pro-thrombotic activity in COPD patients may explain their increased cardiovascular risk. We aim to explore whether short-term exposure to ambient particulate matter is associated with pro-thrombotic changes in adults with and without COPD, and investigate the underlying biological mechanisms in a longitudinal panel study. Serum concentration of thromboxane (Tx)B2 was measured to reflect platelet and pro-thrombotic activity. Lipoxygenase-mediated lipid peroxidation products (hydroxyeicosatetraenoic acids [HETEs]) and inflammatory biomarkers (interleukins [ILs], monocyte chemoattractant protein-1 [MCP-1], tumour necrosis factor alpha [TNF-α], and macrophage inflammatory proteins [MIPs]) were measured as potential mediating determinants of particle-associated pro-thrombotic changes.

RESULTS

53 COPD and 82 non-COPD individuals were followed-up on a maximum of four visits conducted from August 2016 to September 2017 in Beijing, China. Compared to non-COPD individuals, the association between exposure to ambient ultrafine particles (UFPs) during the 3-8 days preceding clinical visits and the TxB2 serum concentration was significantly stronger in COPD patients. For example, a 10/cm increase in the 6-day average UFP level was associated with a 25.4% increase in the TxB2 level in the COPD group but only an 11.2% increase in the non-COPD group. The association in the COPD group remained robust after adjustment for the levels of fine particulate matter and gaseous pollutants. Compared to the non-COPD group, the COPD group also showed greater increases in the serum concentrations of 12-HETE (16.6% vs. 6.5%) and 15-HETE (9.3% vs. 4.5%) per 10/cm increase in the 6-day UFP average. The two lipid peroxidation products mediated 35% and 33% of the UFP-associated increase in the TxB2 level of COPD patients. UFP exposure was also associated with the increased levels of IL-8, MCP-1, MIP-1α, MIP-1β, TNF-α, and IL-1β in COPD patients, but these inflammatory biomarkers did not mediate the TxB2 increase.

CONCLUSIONS

Short-term exposure to ambient UFPs was associated with a greater pro-thrombotic change among patients with COPD, at least partially driven by lipoxygenase-mediated pathways following exposure. Trial registration ChiCTR1900023692 . Date of registration June 7, 2019, i.e. retrospectively registered.

摘要

背景

暴露于颗粒物空气污染与慢性阻塞性肺疾病(COPD)患者的心血管死亡率增加有关,但潜在机制尚不清楚。COPD 患者的血小板和促血栓形成活性增强可能解释了其心血管风险增加。我们旨在探讨短期暴露于环境颗粒物是否与有和没有 COPD 的成年人的促血栓形成变化有关,并在一项纵向面板研究中研究潜在的生物学机制。测量血栓烷(Tx)B2 的血清浓度以反映血小板和促血栓形成活性。测量脂氧合酶介导的脂质过氧化产物(羟二十碳四烯酸[HETEs])和炎症生物标志物(白细胞介素[ILs]、单核细胞趋化蛋白-1 [MCP-1]、肿瘤坏死因子 alpha [TNF-α]和巨噬细胞炎症蛋白[MIPs])作为与颗粒相关的促血栓形成变化的潜在中介决定因素。

结果

2016 年 8 月至 2017 年 9 月期间,在中国北京,最多对 53 名 COPD 患者和 82 名非 COPD 患者进行了 4 次随访。与非 COPD 个体相比,暴露于临床就诊前 3-8 天环境超细颗粒(UFPs)与 COPD 患者 TxB2 血清浓度之间的相关性更强。例如,在 COPD 组中,6 天平均 UFP 水平每增加 10/cm,TxB2 水平增加 25.4%,而非 COPD 组仅增加 11.2%。在调整细颗粒物和气态污染物水平后,COPD 组的相关性仍然很强。与非 COPD 组相比,COPD 组的 12-HETE(16.6%比 6.5%)和 15-HETE(9.3%比 4.5%)血清浓度也分别增加了 10/cm 的 6 天 UFP 平均值。这两种脂质过氧化产物介导了 COPD 患者中 UFP 相关 TxB2 水平增加的 35%和 33%。UFPs 暴露也与 COPD 患者中白细胞介素-8、MCP-1、MIP-1α、MIP-1β、TNF-α和白细胞介素-1β水平的升高有关,但这些炎症生物标志物并没有介导 TxB2 的增加。

结论

短期暴露于环境 UFPs 与 COPD 患者的促血栓形成变化更大有关,至少部分原因是暴露后脂氧合酶介导的途径。试验注册 ChiCTR1900023692. 登记日期 2019 年 6 月 7 日,即回溯性注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fd/9590143/4e02f6819fd6/12989_2022_503_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fd/9590143/b1573c87d5ff/12989_2022_503_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fd/9590143/86ad174bf2f3/12989_2022_503_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fd/9590143/4e02f6819fd6/12989_2022_503_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fd/9590143/b1573c87d5ff/12989_2022_503_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fd/9590143/86ad174bf2f3/12989_2022_503_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6fd/9590143/4e02f6819fd6/12989_2022_503_Fig3_HTML.jpg

相似文献

1
Pro-thrombotic changes associated with exposure to ambient ultrafine particles in patients with chronic obstructive pulmonary disease: roles of lipid peroxidation and systemic inflammation.与慢性阻塞性肺疾病患者暴露于环境超细颗粒相关的促血栓形成变化:脂质过氧化和全身炎症的作用。
Part Fibre Toxicol. 2022 Oct 24;19(1):65. doi: 10.1186/s12989-022-00503-9.
2
Indoor particulate matter concentrations and air cleaner intervention association with biomarkers in former smokers with COPD.室内颗粒物浓度和空气净化器干预与 COPD 戒烟者生物标志物的关系。
Environ Res. 2024 Feb 15;243:117874. doi: 10.1016/j.envres.2023.117874. Epub 2023 Dec 7.
3
Susceptibility of individuals with lung dysfunction to systemic inflammation associated with ambient fine particle exposure: A panel study in Beijing.肺功能障碍个体对环境细颗粒物暴露相关全身炎症的易感性:北京的一项面板研究。
Sci Total Environ. 2021 Sep 20;788:147760. doi: 10.1016/j.scitotenv.2021.147760. Epub 2021 May 15.
4
Susceptibility of individuals with chronic obstructive pulmonary disease to respiratory inflammation associated with short-term exposure to ambient air pollution: A panel study in Beijing.慢性阻塞性肺疾病患者短期暴露于大气污染相关呼吸道炎症的易感性:北京的一项队列研究。
Sci Total Environ. 2021 Apr 20;766:142639. doi: 10.1016/j.scitotenv.2020.142639. Epub 2020 Oct 2.
5
[Effects of exposure to ambient particulate matter and polycyclic aromatic hydrocarbons on oxidative stress biomarkers in the patients with chronic obstructive pulmonary disease].[暴露于环境颗粒物和多环芳烃对慢性阻塞性肺疾病患者氧化应激生物标志物的影响]
Beijing Da Xue Xue Bao Yi Xue Ban. 2017 Jun 18;49(3):394-402.
6
Risk factors in air pollution exposome contributing to higher levels of TNFα in COPD patients.空气污染暴露组学中导致 COPD 患者 TNFα 水平升高的危险因素。
Environ Int. 2022 Jan 15;159:107034. doi: 10.1016/j.envint.2021.107034. Epub 2021 Dec 11.
7
Ambient and Controlled Particle Exposures as Triggers for Acute ECG Changes.环境和受控颗粒暴露作为急性心电图变化的触发因素。
Res Rep Health Eff Inst. 2016 May(186):5-75.
8
Associations between ultrafine particle pollution and daily outpatient visits for respiratory diseases in Shanghai, China: a time-series analysis.中国上海地区细颗粒物污染与呼吸道疾病日门诊量的关联:一项时间序列分析。
Environ Sci Pollut Res Int. 2024 Jan;31(2):3004-3013. doi: 10.1007/s11356-023-31248-3. Epub 2023 Dec 11.
9
Ambient ultrafine particles exacerbate oxygen desaturation during sleep in patients with chronic obstructive pulmonary disease: New insights into the effect spectrum of ultrafine particles on susceptible populations.环境超细颗粒物在慢性阻塞性肺疾病患者睡眠期间加重氧减饱和度:超细颗粒物对易感人群影响谱的新认识。
Sci Total Environ. 2024 Oct 15;947:174519. doi: 10.1016/j.scitotenv.2024.174519. Epub 2024 Jul 6.
10
Fine particulate matter and vasoactive 20-hydroxyeicosatetraenoic acid: Insights into the mechanisms of the prohypertensive effects of particulate air pollution.细颗粒物与血管活性20-羟基二十碳四烯酸:对颗粒物空气污染致高血压作用机制的见解
Sci Total Environ. 2022 Feb 1;806(Pt 3):151298. doi: 10.1016/j.scitotenv.2021.151298. Epub 2021 Oct 29.

引用本文的文献

1
CXCL16/CXCR6 axis arises as a potential peripheral biomarker of early COPD development - results from a pilot study.CXCL16/CXCR6轴作为慢性阻塞性肺疾病(COPD)早期发展的潜在外周生物标志物——一项初步研究的结果
Front Med (Lausanne). 2025 Jul 9;12:1636360. doi: 10.3389/fmed.2025.1636360. eCollection 2025.
2
Natural ingredients in the regulation of abnormal lipid peroxidation: a potential therapy for pulmonary diseases.天然成分对异常脂质过氧化的调节作用:一种肺部疾病的潜在治疗方法。
Front Pharmacol. 2024 Dec 20;15:1507194. doi: 10.3389/fphar.2024.1507194. eCollection 2024.
3
Mechanism underlying the therapeutic effects of effective component compatibility of Bufei Yishen formula III combined with exercise rehabilitation on chronic obstructive pulmonary disease.

本文引用的文献

1
Proinflammatory lipid signals trigger the health effects of air pollution in individuals with prediabetes.促炎脂质信号触发了糖尿病前期个体中空气污染的健康影响。
Environ Pollut. 2021 Dec 1;290:118008. doi: 10.1016/j.envpol.2021.118008. Epub 2021 Aug 24.
2
Platelet activation by charged ligands and nanoparticles: platelet glycoprotein receptors as pattern recognition receptors.带电荷配体和纳米颗粒对血小板的激活:血小板糖蛋白受体作为模式识别受体。
Platelets. 2021 Nov 17;32(8):1018-1030. doi: 10.1080/09537104.2021.1945571. Epub 2021 Jul 16.
3
Global burden of COPD attributable to ambient PM2.5 in 204 countries and territories, 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019.
补肺益肾方有效部位配伍联合运动康复治疗慢性阻塞性肺疾病作用机制。
Ann Med. 2024 Dec;56(1):2403729. doi: 10.1080/07853890.2024.2403729. Epub 2024 Sep 14.
4
Indoor particulate matter concentrations and air cleaner intervention association with biomarkers in former smokers with COPD.室内颗粒物浓度和空气净化器干预与 COPD 戒烟者生物标志物的关系。
Environ Res. 2024 Feb 15;243:117874. doi: 10.1016/j.envres.2023.117874. Epub 2023 Dec 7.
5
Exposome and unhealthy aging: environmental drivers from air pollution to occupational exposures.暴露组学与非健康老龄化:从空气污染到职业暴露的环境驱动因素。
Geroscience. 2023 Dec;45(6):3381-3408. doi: 10.1007/s11357-023-00913-3. Epub 2023 Sep 9.
6
The Effects and Pathogenesis of PM2.5 and Its Components on Chronic Obstructive Pulmonary Disease.PM2.5 及其成分对慢性阻塞性肺疾病的影响及发病机制。
Int J Chron Obstruct Pulmon Dis. 2023 Apr 6;18:493-506. doi: 10.2147/COPD.S402122. eCollection 2023.
204 个国家和地区 1990 年至 2019 年与环境 PM2.5 相关的 COPD 全球负担:2019 年全球疾病负担研究的系统分析。
Sci Total Environ. 2021 Nov 20;796:148819. doi: 10.1016/j.scitotenv.2021.148819. Epub 2021 Jul 9.
4
Association between exposure to polycyclic aromatic hydrocarbons and lipid peroxidation in patients with chronic obstructive pulmonary disease.多环芳烃暴露与慢性阻塞性肺疾病患者脂质过氧化的关系。
Sci Total Environ. 2021 Aug 1;780:146660. doi: 10.1016/j.scitotenv.2021.146660. Epub 2021 Mar 22.
5
Susceptibility of individuals with lung dysfunction to systemic inflammation associated with ambient fine particle exposure: A panel study in Beijing.肺功能障碍个体对环境细颗粒物暴露相关全身炎症的易感性:北京的一项面板研究。
Sci Total Environ. 2021 Sep 20;788:147760. doi: 10.1016/j.scitotenv.2021.147760. Epub 2021 May 15.
6
Particulate Matter and Cardiovascular Risk in Adults with Chronic Obstructive Pulmonary Disease.颗粒物与慢性阻塞性肺疾病成人的心血管风险。
Am J Respir Crit Care Med. 2021 Jul 15;204(2):159-167. doi: 10.1164/rccm.202007-2901OC.
7
Exposure to fine particulate matter promotes platelet activation and thrombosis via obesity-related inflammation.暴露于细颗粒物会通过与肥胖相关的炎症促进血小板活化和血栓形成。
J Hazard Mater. 2021 Jul 5;413:125341. doi: 10.1016/j.jhazmat.2021.125341. Epub 2021 Feb 6.
8
Changes in bioactive lipid mediators in response to short-term exposure to ambient air particulate matter: A targeted lipidomic analysis of oxylipin signaling pathways.短期暴露于环境空气颗粒物后生物活性脂质介质的变化:氧化应激脂质信号通路的靶向脂质组学分析。
Environ Int. 2021 Feb;147:106314. doi: 10.1016/j.envint.2020.106314. Epub 2020 Dec 14.
9
A rapid and high-throughput approach to quantify non-esterified oxylipins for epidemiological studies using online SPE-LC-MS/MS.采用在线 SPE-LC-MS/MS 对流行病学研究中的非酯化氧化脂质进行快速高通量定量的方法。
Anal Bioanal Chem. 2020 Nov;412(28):7989-8001. doi: 10.1007/s00216-020-02931-y. Epub 2020 Sep 18.
10
Respiratory Inflammation and Short-Term Ambient Air Pollution Exposures in Adult Beijing Residents with and without Prediabetes: A Panel Study.有和无糖尿病前期的北京成年居民中呼吸道炎症与短期环境大气污染暴露:一项面板研究。
Environ Health Perspect. 2020 Jun;128(6):67004. doi: 10.1289/EHP4906. Epub 2020 Jun 1.